Skip to content

Medical Grand Rounds: Updates in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma

In This Article

  • The Division of Gastroenterology at Massachusetts General Hospital presented at the virtual Department of Medicine Medical Grand Rounds
  • Kathleen Corey, MD, MPH, MMSc, presented on the non-invasive assessment of non-alcoholic fatty liver disease
  • Tracey Simon, MD, MPH, discussed prevention strategies for hepatocellular carcinoma

On March 9, 2023, the Division of Gastroenterology at Massachusetts General Hospital led a virtual Department of Medicine Medical Grand Rounds presentation.

The panel included Kathleen Corey, MD, MPH, MMSc, director of the Fatty Liver Program and associate professor of Medicine at Harvard Medical School, and Tracey Simon, MD, MPH, hepatologist in the Division of Gastroenterology and assistant professor of Medicine at Harvard Medical School.

Dr. Corey discussed risk factors for non-alcoholic fatty liver disease (NAFLD) and the importance of identifying fibrosis in patients with NAFLD to guide management. Dr. Simon presented prevention strategies for hepatocellular carcinoma, the incidence and mortality rates of which are increasing at an alarming pace.

Watch the video »

Visit the Division of Gastroenterology

Refer a patient to the Division of Gastroenterology

Related topics


Cardiovascular disease, higher body mass index and CD4 count <200 cells/mm3 were significantly associated with nonalcoholic fatty liver disease among adults with HIV, even after adjustment for traditional cardiovascular disease risk factors.


In a large prospective cohort of U.S. women, Massachusetts General Hospital researchers found that a higher intake of red meat contributed to a significant, dose-dependent increased risk of developing nonalcoholic fatty liver disease, and this association was largely mediated by obesity.